Collection activity
Discover the latest 100 records added to PeptideScanner across 4 evidence lanes. “Added” is the site publication date; each card separately shows the date carried by the cited source.
Regulatory · Added to PeptideScanner
DailyMed lists Structured Product Labeling version 40 for the reviewed Tirzepatide label family with a published date of 2026-09-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Regulatory record date September 2, 2026 · Tirzepatide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT03811561 at 2026-09-09T19:17:17.089Z. Its registry update date was 2026-09-09, and PeptideScanner's reviewed identity mapping was semaglutide.↗
Registry update September 9, 2026 · Semaglutide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT06926842 at 2026-09-09T19:17:17.080Z. Its registry update date was 2026-09-09, and PeptideScanner's reviewed identity mapping was petrelintide.↗
Registry update September 9, 2026 · Petrelintide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT07247084 at 2026-09-09T19:17:17.101Z. Its registry update date was 2026-09-09, and PeptideScanner's reviewed identity mapping was tirzepatide.↗
Registry update September 9, 2026 · Tirzepatide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT07662213 at 2026-09-09T19:17:17.121Z. Its registry update date was 2026-09-09, and PeptideScanner's reviewed identity mapping was semaglutide.↗
Registry update September 9, 2026 · Semaglutide
Literature metadata · Added to PeptideScanner
PubMed lists PMID 40536021 in Qualitative health research as Journal Article, with publication-date metadata of 2025-06-19 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
PubMed metadata revision September 9, 2026 · Attributed publication date June 19, 2025 (day precision) · Semaglutide
Literature metadata · Added to PeptideScanner
PubMed lists PMID 42332291 in Cellular and molecular life sciences : CMLS as Journal Article, with publication-date metadata of 2026-06-22 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
PubMed metadata revision September 9, 2026 · Attributed publication date June 22, 2026 (day precision) · Glucagon
Literature metadata · Added to PeptideScanner
PubMed lists PMID 42712757 in Frontiers in endocrinology as Journal Article, Randomized Controlled Trial, Clinical Trial, with publication-date metadata of 2026-08-25 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
PubMed metadata revision September 9, 2026 · Attributed publication date August 25, 2026 (day precision) · Octreotide
Literature metadata · Added to PeptideScanner
PubMed lists PMID 42713641 in NEJM evidence as Journal Article, with publication-date metadata of 2026-09-09 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
PubMed metadata revision September 9, 2026 · Attributed publication date September 9, 2026 (day precision) · Vosoritide
Literature metadata · Added to PeptideScanner
PubMed lists PMID 42708757 in Analytical chemistry as Journal Article, with publication-date metadata of 2026-09-08 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
PubMed metadata revision September 8, 2026 · Attributed publication date September 8, 2026 (day precision) · Liraglutide
Literature metadata · Added to PeptideScanner
PubMed lists PMID 42708867 in Physiological research as Journal Article, Comparative Study, with publication-date metadata of 2026-08-31 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
PubMed metadata revision September 8, 2026 · Attributed publication date August 31, 2026 (day precision) · Elamipretide
Literature metadata · Added to PeptideScanner
PubMed lists PMID 42709517 in Pharmaceutical development and technology as Journal Article, with publication-date metadata of 2026-09-08 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
PubMed metadata revision September 8, 2026 · Attributed publication date September 8, 2026 (day precision) · Exenatide
Literature metadata · Added to PeptideScanner
PubMed lists PMID 42703141 in JPMA. The Journal of the Pakistan Medical Association as Journal Article, with publication-date metadata of 2026-08 (month precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
PubMed metadata revision September 7, 2026 · Attributed publication date August 2026 (month precision) · Semaglutide
Literature metadata · Added to PeptideScanner
PubMed lists PMID 42703150 in JPMA. The Journal of the Pakistan Medical Association as Journal Article, with publication-date metadata of 2026-08 (month precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
PubMed metadata revision September 7, 2026 · Attributed publication date August 2026 (month precision) · Semaglutide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT06439277 at 2026-09-09T19:17:17.406Z. Its registry update date was 2026-09-04, and PeptideScanner's reviewed identity mapping was tirzepatide.↗
Registry update September 4, 2026 · Tirzepatide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT06851962 at 2026-09-09T19:17:17.407Z. Its registry update date was 2026-09-04, and PeptideScanner's reviewed identity mapping was dulaglutide.↗
Registry update September 4, 2026 · Dulaglutide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT07803705 at 2026-09-09T19:17:17.113Z. Its registry update date was 2026-09-04, and PeptideScanner's reviewed identity mapping was mazdutide.↗
Registry update September 4, 2026 · Mazdutide
Literature metadata · Added to PeptideScanner
PubMed lists PMID 42695200 in Oral diseases as Letter, with publication-date metadata of 2026-09-04 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
PubMed metadata revision September 4, 2026 · Attributed publication date September 4, 2026 (day precision) · Tirzepatide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT07684144 at 2026-09-09T19:17:17.403Z. Its registry update date was 2026-09-03, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.↗
Registry update September 3, 2026 · Maridebart cafraglutide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT07801664 at 2026-09-09T19:17:17.074Z. Its registry update date was 2026-09-03, and PeptideScanner's reviewed identity mapping was leuprolide.↗
Registry update September 3, 2026 · Leuprolide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT07803250 at 2026-09-09T19:17:17.410Z. Its registry update date was 2026-09-03, and PeptideScanner's reviewed identity mapping was bpc-157.↗
Registry update September 3, 2026 · BPC-157
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT07083154 at 2026-09-09T19:17:17.091Z. Its registry update date was 2026-09-02, and PeptideScanner's reviewed identity mapping was mazdutide.↗
Registry update September 2, 2026 · Mazdutide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT07795164 at 2026-09-09T19:17:17.076Z. Its registry update date was 2026-08-31, and PeptideScanner's reviewed identity mapping was pemvidutide.↗
Registry update August 31, 2026 · Pemvidutide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT07575399 at 2026-09-09T19:17:17.083Z. Its registry update date was 2026-08-27, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.↗
Registry update August 27, 2026 · Maridebart cafraglutide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT06383390 at 2026-09-09T19:17:17.103Z. Its registry update date was 2026-08-24, and PeptideScanner's reviewed identity mapping was retatrutide.↗
Registry update August 24, 2026 · Retatrutide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT07596212 at 2026-09-09T19:17:17.112Z. Its registry update date was 2026-08-24, and PeptideScanner's reviewed identity mapping was leuprolide.↗
Registry update August 24, 2026 · Leuprolide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT05929066 at 2026-09-09T19:17:17.407Z. Its registry update date was 2026-08-21, and PeptideScanner's reviewed identity mapping was retatrutide.↗
Registry update August 21, 2026 · Retatrutide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT07313813 at 2026-09-09T19:17:17.407Z. Its registry update date was 2026-08-21, and PeptideScanner's reviewed identity mapping was dulaglutide.↗
Registry update August 21, 2026 · Dulaglutide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT07225829 at 2026-08-10T18:10:03.940Z. Its registry update date was 2026-07-27, and PeptideScanner's reviewed identity mapping was liraglutide.↗
Registry update July 27, 2026 · Liraglutide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT07674290 at 2026-07-30T16:19:03.062Z. Its registry update date was 2026-06-29, and PeptideScanner's reviewed identity mapping was setmelanotide.↗
Registry update June 29, 2026 · Setmelanotide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT07607587 at 2026-07-30T16:19:03.059Z. Its registry update date was 2026-06-25, and PeptideScanner's reviewed identity mapping was cagrilintide.↗
Registry update June 25, 2026 · Cagrilintide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT07413913 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-15, and PeptideScanner's reviewed identity mapping was survodutide.↗
Registry update June 15, 2026 · Survodutide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT04575844 at 2026-07-30T16:19:36.923Z. Its registry update date was 2026-05-06, and PeptideScanner's reviewed identity mapping was liraglutide.↗
Registry update May 6, 2026 · Liraglutide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT07411560 at 2026-07-30T16:20:49.304Z. Its registry update date was 2026-04-13, and PeptideScanner's reviewed identity mapping was cagrilintide.↗
Registry update April 13, 2026 · Cagrilintide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT03139305 at 2026-07-30T16:22:22.326Z. Its registry update date was 2026-03-30, and PeptideScanner's reviewed identity mapping was glucagon.↗
Registry update March 30, 2026 · Glucagon
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT03989947 at 2026-07-30T16:22:22.327Z. Its registry update date was 2026-03-13, and PeptideScanner's reviewed identity mapping was vosoritide.↗
Registry update March 13, 2026 · Vosoritide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT06760546 at 2026-07-30T16:23:45.658Z. Its registry update date was 2026-02-12, and PeptideScanner's reviewed identity mapping was setmelanotide.↗
Registry update February 12, 2026 · Setmelanotide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT07076030 at 2026-07-30T16:25:18.009Z. Its registry update date was 2026-01-28, and PeptideScanner's reviewed identity mapping was petrelintide.↗
Registry update January 28, 2026 · Petrelintide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT05760313 at 2026-07-30T16:25:18.002Z. Its registry update date was 2026-01-06, and PeptideScanner's reviewed identity mapping was linaclotide.↗
Registry update January 6, 2026 · Linaclotide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT06588504 at 2026-07-30T18:18:33.514Z. Its registry update date was 2025-12-05, and PeptideScanner's reviewed identity mapping was glucagon.↗
Registry update December 5, 2025 · Glucagon
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT04321408 at 2026-07-30T18:23:09.829Z. Its registry update date was 2025-08-17, and PeptideScanner's reviewed identity mapping was ziconotide.↗
Registry update August 17, 2025 · Ziconotide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT04561245 at 2026-07-30T18:26:04.261Z. Its registry update date was 2025-06-24, and PeptideScanner's reviewed identity mapping was pemvidutide.↗
Registry update June 24, 2025 · Pemvidutide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT04179734 at 2026-07-30T18:41:37.916Z. Its registry update date was 2024-08-09, and PeptideScanner's reviewed identity mapping was bremelanotide.↗
Registry update August 9, 2024 · Bremelanotide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT03891875 at 2026-07-30T18:42:56.626Z. Its registry update date was 2024-07-12, and PeptideScanner's reviewed identity mapping was elamipretide.↗
Registry update July 12, 2024 · Elamipretide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT02981069 at 2026-07-30T19:10:42.759Z. Its registry update date was 2023-07-20, and PeptideScanner's reviewed identity mapping was exenatide.↗
Registry update July 20, 2023 · Exenatide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT01364584 at 2026-07-30T19:10:42.711Z. Its registry update date was 2023-07-12, and PeptideScanner's reviewed identity mapping was exenatide.↗
Registry update July 12, 2023 · Exenatide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT02025179 at 2026-07-30T19:13:03.751Z. Its registry update date was 2023-05-10, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Registry update May 10, 2023 · Teriparatide
Literature metadata · Added to PeptideScanner
PubMed lists PMID 36565004 in Alimentary pharmacology & therapeutics as Editorial, Comment, with publication-date metadata of 2023-01 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
PubMed metadata revision February 26, 2023 · Attributed publication date January 2023 (month precision) · Linaclotide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT04750460 at 2026-07-30T19:32:59.860Z. Its registry update date was 2022-11-10, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Registry update November 10, 2022 · Teriparatide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT03973047 at 2026-07-30T19:40:58.916Z. Its registry update date was 2022-04-04, and PeptideScanner's reviewed identity mapping was bremelanotide.↗
Registry update April 4, 2022 · Bremelanotide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT02693119 at 2026-07-30T19:56:31.565Z. Its registry update date was 2021-11-30, and PeptideScanner's reviewed identity mapping was elamipretide.↗
Registry update November 30, 2021 · Elamipretide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT02055157 at 2026-07-30T20:07:13.490Z. Its registry update date was 2021-01-15, and PeptideScanner's reviewed identity mapping was vosoritide.↗
Registry update January 15, 2021 · Vosoritide
Literature metadata · Added to PeptideScanner
PubMed lists PMID 33251034 in World journal of gastrointestinal pharmacology and therapeutics as Journal Article, with publication-date metadata of 2020-11-08 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
PubMed metadata revision December 30, 2020 · Attributed publication date November 8, 2020 (day precision) · BPC-157
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT03573908 at 2026-07-30T20:18:37.978Z. Its registry update date was 2020-12-01, and PeptideScanner's reviewed identity mapping was linaclotide.↗
Registry update December 1, 2020 · Linaclotide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT01982240 at 2026-07-30T20:42:14.439Z. Its registry update date was 2019-12-26, and PeptideScanner's reviewed identity mapping was plecanatide.↗
Registry update December 26, 2019 · Plecanatide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT03120520 at 2026-07-30T20:44:36.699Z. Its registry update date was 2019-10-04, and PeptideScanner's reviewed identity mapping was plecanatide.↗
Registry update October 4, 2019 · Plecanatide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT02493517 at 2026-07-30T20:57:18.712Z. Its registry update date was 2019-01-29, and PeptideScanner's reviewed identity mapping was lanreotide.↗
Registry update January 29, 2019 · Lanreotide
Literature metadata · Added to PeptideScanner
PubMed lists PMID 8813476 in Digestion as Clinical Trial, Journal Article, Multicenter Study, with publication-date metadata of 1996 (year precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
PubMed metadata revision February 16, 2018 · Attributed publication date 1996 (year precision) · Lanreotide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT02217800 at 2026-07-30T21:12:47.415Z. Its registry update date was 2018-02-15, and PeptideScanner's reviewed identity mapping was octreotide.↗
Registry update February 15, 2018 · Octreotide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT02745470 at 2026-07-30T21:22:00.254Z. Its registry update date was 2017-11-29, and PeptideScanner's reviewed identity mapping was lixisenatide.↗
Registry update November 29, 2017 · Lixisenatide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT01888120 at 2026-07-30T21:25:36.852Z. Its registry update date was 2017-03-16, and PeptideScanner's reviewed identity mapping was ziconotide.↗
Registry update March 16, 2017 · Ziconotide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT00206297 at 2026-07-30T21:36:16.909Z. Its registry update date was 2016-07-14, and PeptideScanner's reviewed identity mapping was pramlintide.↗
Registry update July 14, 2016 · Pramlintide
Clinical trials · Added to PeptideScanner
PeptideScanner retained ClinicalTrials.gov record NCT02012556 at 2026-07-30T21:55:56.632Z. Its registry update date was 2013-12-16, and PeptideScanner's reviewed identity mapping was tesamorelin.↗
Registry update December 16, 2013 · Tesamorelin
Literature metadata · Added to PeptideScanner
PubMed lists PMID 16314038 in European urology as Journal Article, with publication-date metadata of 2005-11-15 (day precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
PubMed metadata revision November 21, 2013 · Attributed publication date November 15, 2005 (day precision) · Leuprolide
Literature metadata · Added to PeptideScanner
PubMed lists PMID 18843769 in The Journal of rheumatology as Case Reports, Letter, with publication-date metadata of 2008-10 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
PubMed metadata revision November 21, 2013 · Attributed publication date October 2008 (month precision) · Teriparatide
Literature metadata · Added to PeptideScanner
PubMed lists PMID 2059523 in Revista espanola de enfermedades digestivas as English Abstract, Journal Article, with publication-date metadata of 1991-02 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
PubMed metadata revision November 21, 2013 · Attributed publication date February 1991 (month precision) · Octreotide
Literature metadata · Added to PeptideScanner
PubMed lists PMID 10082630 in General and comparative endocrinology as Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 1999-02 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
PubMed metadata revision November 15, 2006 · Attributed publication date February 1999 (month precision) · Glucagon
Literature metadata · Added to PeptideScanner
PubMed lists PMID 8224771 in General and comparative endocrinology as Comparative Study, Journal Article, with publication-date metadata of 1993-09 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
PubMed metadata revision November 15, 2006 · Attributed publication date September 1993 (month precision) · Glucagon
Literature metadata · Added to PeptideScanner
PubMed lists PMID 8319563 in Endocrinology as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1993-07 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
PubMed metadata revision November 15, 2006 · Attributed publication date July 1993 (month precision) · Glucagon
Literature metadata · Added to PeptideScanner
PubMed lists PMID 8386505 in Biochemical and biophysical research communications as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1993-04-15 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
PubMed metadata revision November 15, 2006 · Attributed publication date April 15, 1993 (day precision) · Glucagon
Literature metadata · Added to PeptideScanner
PubMed lists PMID 8405897 in General and comparative endocrinology as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 1993-07 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
PubMed metadata revision November 15, 2006 · Attributed publication date July 1993 (month precision) · Glucagon
Literature metadata · Added to PeptideScanner
PubMed lists PMID 9795700 in Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1998-10 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
PubMed metadata revision November 15, 2006 · Attributed publication date October 1998 (month precision) · Glucagon
Safety · Added to PeptideScanner
FDA's dated enforcement report D-0723-2026 lists Class II and source status Ongoing for Lupin Pharmaceuticals Inc. PeptideScanner connects the report to reviewed application ANDA214457 through exact openFDA application-number annotations.↗
Source record date July 8, 2026 · Glucagon
Safety · Added to PeptideScanner
FDA's dated enforcement report D-0541-2026 lists Class II and source status Ongoing for Lupin Pharmaceuticals Inc. PeptideScanner connects the report to reviewed application ANDA215421 through exact openFDA application-number annotations.↗
Source record date May 27, 2026 · Liraglutide
Safety · Added to PeptideScanner
FDA's dated enforcement report D-0519-2026 lists Class II and source status Ongoing for Teva Pharmaceuticals USA, Inc. PeptideScanner connects the report to reviewed application ANDA210317 through exact openFDA application-number annotations.↗
Source record date May 13, 2026 · Octreotide
Safety · Added to PeptideScanner
FDA's dated enforcement report D-0422-2026 lists Class II and source status Ongoing for Cipla USA, Inc. PeptideScanner connects the report to reviewed application NDA215395 through exact openFDA application-number annotations.↗
Source record date April 15, 2026 · Lanreotide
Safety · Added to PeptideScanner
FDA's dated enforcement report D-0423-2026 lists Class II and source status Ongoing for Cipla USA, Inc. PeptideScanner connects the report to reviewed application ANDA217193 through exact openFDA application-number annotations.↗
Source record date April 15, 2026 · Lanreotide
Safety · Added to PeptideScanner
FDA's dated enforcement report D-0404-2026 lists Class II and source status Ongoing for Teva Pharmaceuticals USA, Inc. PeptideScanner connects the report to reviewed application ANDA210317 through exact openFDA application-number annotations.↗
Source record date April 1, 2026 · Octreotide
Safety · Added to PeptideScanner
FDA's dated enforcement report D-0405-2026 lists Class II and source status Ongoing for Teva Pharmaceuticals USA, Inc. PeptideScanner connects the report to reviewed application ANDA210317 through exact openFDA application-number annotations.↗
Source record date April 1, 2026 · Octreotide
Safety · Added to PeptideScanner
FDA's dated enforcement report D-0406-2026 lists Class II and source status Ongoing for Teva Pharmaceuticals USA, Inc. PeptideScanner connects the report to reviewed application ANDA210317 through exact openFDA application-number annotations.↗
Source record date April 1, 2026 · Octreotide
Safety · Added to PeptideScanner
FDA's dated enforcement report D-0290-2026 lists Class II and source status Ongoing for Cipla USA, Inc. PeptideScanner connects the report to reviewed application NDA215395 through exact openFDA application-number annotations.↗
Source record date January 21, 2026 · Lanreotide
Safety · Added to PeptideScanner
FDA's dated enforcement report D-1178-2023 lists Class III and source status Terminated for Tolmar, Inc. PeptideScanner connects the report to reviewed application NDA021379 through exact openFDA application-number annotations.↗
Source record date October 4, 2023 · Leuprolide
Safety · Added to PeptideScanner
FDA's dated enforcement report D-0058-2023 lists Class I and source status Terminated for Viatris Inc. PeptideScanner connects the report to reviewed application ANDA079198 through exact openFDA application-number annotations.↗
Source record date November 16, 2022 · Octreotide
Safety · Added to PeptideScanner
FDA's dated enforcement report D-0884-2022 lists Class II and source status Completed for Cardinal Health Inc. PeptideScanner connects the report to reviewed application BLA125469 through exact openFDA application-number annotations.↗
Source record date May 25, 2022 · Dulaglutide
Safety · Added to PeptideScanner
FDA's dated enforcement report D-0773-2021 lists Class II and source status Terminated for Eli Lilly & Company. PeptideScanner connects the report to reviewed application BLA125469 through exact openFDA application-number annotations.↗
Source record date September 1, 2021 · Dulaglutide
Safety · Added to PeptideScanner
FDA's dated enforcement report D-0417-2021 lists Class II and source status Terminated for Cardinal Health Inc. PeptideScanner connects the report to reviewed application NDA202811 through exact openFDA application-number annotations.↗
Source record date June 2, 2021 · Linaclotide
Safety · Added to PeptideScanner
FDA's dated enforcement report D-0536-2021 lists Class II and source status Terminated for Cardinal Health Inc. PeptideScanner connects the report to reviewed application NDA213051 through exact openFDA application-number annotations.↗
Source record date June 2, 2021 · Semaglutide
Safety · Added to PeptideScanner
FDA's dated enforcement report D-0618-2021 lists Class II and source status Terminated for Novo Nordisk Inc. PeptideScanner connects the report to reviewed application NDA206321 through exact openFDA application-number annotations.↗
Source record date April 21, 2021 · Liraglutide
Safety · Added to PeptideScanner
FDA's dated enforcement report D-0622-2021 lists Class II and source status Terminated for Novo Nordisk Inc. PeptideScanner connects the report to reviewed application NDA022341 through exact openFDA application-number annotations.↗
Source record date April 21, 2021 · Liraglutide
Safety · Added to PeptideScanner
FDA's dated enforcement report D-1287-2014 lists Class II and source status Terminated for AbbVie Inc. PeptideScanner connects the report to reviewed application NDA020517 through exact openFDA application-number annotations.↗
Source record date May 7, 2014 · Leuprolide
Safety · Added to PeptideScanner
FDA's dated enforcement report D-1288-2014 lists Class II and source status Terminated for AbbVie Inc. PeptideScanner connects the report to reviewed application NDA020517 through exact openFDA application-number annotations.↗
Source record date May 7, 2014 · Leuprolide
Safety · Added to PeptideScanner
FDA's dated enforcement report D-1289-2014 lists Class II and source status Terminated for AbbVie Inc. PeptideScanner connects the report to reviewed application NDA020263 through exact openFDA application-number annotations.↗
Source record date May 7, 2014 · Leuprolide
Safety · Added to PeptideScanner
FDA's dated enforcement report D-1290-2014 lists Class II and source status Terminated for AbbVie Inc. PeptideScanner connects the report to reviewed application NDA020708 through exact openFDA application-number annotations.↗
Source record date May 7, 2014 · Leuprolide
Safety · Added to PeptideScanner
FDA's dated enforcement report D-1291-2014 lists Class II and source status Terminated for AbbVie Inc. PeptideScanner connects the report to reviewed application NDA020517 through exact openFDA application-number annotations.↗
Source record date May 7, 2014 · Leuprolide
Regulatory · Added to PeptideScanner
DailyMed lists Structured Product Labeling version 19 for the reviewed Abaloparatide label family with a published date of 2026-08-17. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Regulatory record date August 17, 2026 · Abaloparatide
Regulatory · Added to PeptideScanner
DailyMed lists Structured Product Labeling version 62 for the reviewed Dulaglutide label family with a published date of 2026-08-10. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Regulatory record date August 10, 2026 · Dulaglutide
Regulatory · Added to PeptideScanner
DailyMed lists Structured Product Labeling version 9 for the reviewed Tesamorelin label family with a published date of 2026-07-31. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Regulatory record date July 31, 2026 · Tesamorelin
Regulatory · Added to PeptideScanner
DailyMed lists Structured Product Labeling version 6 for the reviewed Liraglutide label family with a published date of 2026-07-14. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Regulatory record date July 14, 2026 · Liraglutide
Regulatory · Added to PeptideScanner
DailyMed lists Structured Product Labeling version 2 for the reviewed Glucagon label family with a published date of 2026-07-09. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Regulatory record date July 9, 2026 · Glucagon
Regulatory · Added to PeptideScanner
DailyMed lists Structured Product Labeling version 5 for the reviewed Insulin glargine-aldy label family with a published date of 2026-07-08. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Regulatory record date July 8, 2026 · Insulin glargine-aldy